EGFR and neoplasm: We hypothesized that NK cells in combination with cetuximab could enhance the cytotoxic effects of cetuximab in EGFR+ RASwt/mut BRAFmut CRCs, besides NK cell natural cytotoxicity can mediate anti-tumor activity on EGFR- CRCs that do not respond to anti-EGFR therapy.